A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：CLINICAL AND TRANSLATIONAL ALLERGY ISSN： 2045-7022 出版频率： Monthly 出版社： WILEY, 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774   出版社网址： http://www.biomedcentral.com/ 期刊网址： http://ctajournal.biomedcentral.com/ 影响因子： 5.871 主题范畴： ALLERGY 变更情况： Newly Added by 2016 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and scope Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease. Beyond original research, Clinical and Translational Allergy also accepts structured reviews as well as opinion based reviews, and different position publications from EAACI or its National Societies. Open access publishing enables free access to all content ensuring a wide dissemination of articles; the electronic format and expert peer review allows for very rapid publication. Clinical and Translational Allergy is an international journal reaching out far beyond the borders of Europe, and invites clinicians and researchers from all countries of the world to contribute. Open access All articles published by Clinical and Translational Allergy are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in Clinical and Translational Allergy you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges Open access publishing is not without costs. Clinical and Translational Allergy therefore levies an article-processing charge of £1470/$2300/€1875 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. Indexing services All articles published in Clinical and Translational Allergy are included in: CAS DOAJ Embase PubMed PubMed Central Scopus The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink. We are working closely with relevant indexing services including Web of Science (Thomson Reuters) to ensure that articles published in Clinical and Translational Allergy will be available in their databases when appropriate. Peer-review policy Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here. Clinical and Translational Allergy operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript. The Editor-in-Chief or nominated Handling Editor will invite appropriate reviewers, who will who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board. Editorial policies All manuscripts submitted to Clinical and Translational Allergy should adhere to BioMed Central's editorial policies. Citing articles in Clinical and Translational Allergy Articles in Clinical and Translational Allergy  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number. Article citations follow this format: Authors: Title. Clin Transl Allergy [year], [volume number]:[article number]. e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Clin Transl Allergy 2009, 1:115. refers to article 115 from Volume 1 of the journal. Appeals and complaints If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher. Why publish your article in Clinical and Translational Allergy High visibility Clinical and Translational Allergy's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.  Speed of publication Clinical and Translational Allergy offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF. Flexibility Online publication in Clinical and Translational Allergy gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles). Promotion and press coverage Articles published in Clinical and Translational Allergy are included in article alerts and regular email updates. Some may be highlighted on Clinical and Translational Allergy’s pages and on the BioMed Central homepage. In addition, articles published in Clinical and Translational Allergy may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Clinical and Translational Allergy. A list of articles recently press-released by journals published by BioMed Central is available here. Copyright As an author of an article published in Clinical and Translational Allergy you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement). For further information about the advantages of publishing in a journal from BioMed Central, please click here. Instructions to Authors Submission guidelines Our 3-step submission process Before you submit Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit. Make sure you are submitting to the most suitable journal - Aims and scope Understand the costs and funding options - Fees and funding Make sure your manuscript is accurate and readable - Language editing services Understand the copyright agreement - Copyright Ready to submit To give your manuscript the best chance of publication, follow these policies and formatting guidelines. Clinical and Translational Allergy publishes the following article types: Research Reviews Brief communications Editorials Letters to the Editor Study protocols Click the relevant link to find style and formatting information for the article you are going to submit. General formatting rules for all article types - Preparing your manuscript Make sure your submission is complete - Prepare supporting information Copyright and license agreement - Conditions of publication Read and agree to our Editorial Policies - Editorial policies Submit and promote After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Who decides whether my work will be accepted? - Peer-review policy Want to submit to a different journal? - Manuscript transfers Spreading the word - Promoting your publication Submit your manuscript in Editorial Manager Editorial Board Editors-in-Chief Jean Bousquet, University of Montpellier, France Clive Grattan, Norfolk and Norwich University Hospital, UK Associate Editors Ioana Agache, Transylvania University, Romania Claudia Alessandri, Centri Associati Allergologia Molecolare, Italy Alberto Alvarez-Perea, Hospital Materno Infantil Gregorio Maranon, Spain Montserrat Alvaro, Hospital Sant Joan de Déu, University of Barcelona, Spain Onur Boyman, University of Zurich, Switzerland  Victoria Cardona, Hospital Universitari Vall d'Hebron, Spain Moisés A Calderon, Imperial College London, UK Gennaro D'Amato, University of Naples Federico II, Italy Stefano R. Del Giacco, University of Cagliari, Italy Hanneke (J.N.G.) Oude Elberink, University Medical Center Groningen, The Netherlands Fatima Ferreira, University of Salzburg, Austria James Gardner, Great North Children's Hospital, Newcastle Philippe Gevaert, Ghent University, Belgium Lars Jacobsen, Allergy Leaning, ALC, Denmark Marek Jutel, Wroclaw Medical University, Poland  Omer Kalayci, Hacettepe University, Turkey George Konstantinou, 424 General Military Training Hospital, Greece Marcin Kurowski, Medical University of Lodz, Poland Andrea Leonardi, University of Padua, Italy Ralf Mueller, Ludwig Maximilian University of Munich, Germany Antonella Muraro, Padua General Hospital, Italy Liam O'Mahony, University of Zurich, Switzerland Nikos Papadopoulos, University of Athens, Greece Lars K Poulsen, Copenhagen University Hospital, Denmark Dermot Ryan, University of Edinburgh, UK Hermelijn H. Smits, Leiden University Medical Center, The Netherlands Radoslaw Spiewak, Jagiellonian University Medical College, Poland Maria J Torres, Regional University Hospital of Malaga, Spain Editorial Advisory Board Sevim Bavbek, Ankara University, School of Medicine, Division of Immunology, Turkey Fulvio Braido, University of Genoa, Italy  Yoon-Seok Chang, Seoul National University Bundang Hospital, South Korea Luis Delgado, Faculdade Medicina, Universidade Porto, Portugal Pascal Demoly, University Hospital of Montpellier, France Philippe Eigenmann, University Hospitals of Geneva, Switzerland Penny Fitzharris, Auckland District Health Board, New Zealand Wytske Fokkens, Academic Medical Center, Amsterdam, Netherlands Roy Gerth van Wijk, Erasmus MC-University Medical Center, Netherlands Kiran Godse, Dr. D. Y. Patil Medical College and Hospital, India Peter Hellings, University Hospitals Leuven, Belgium Michihiro Hide, Hiroshima University, Japan Marek Jutel, Wroclaw Medical University, Poland Edward Knol, University Medical Center Utrecht, Netherlands Lin-Feng Li, Peking University, China Jan Lötvall, Göteborg University, Sweden Carmen Rondon, Regional University Hospital of Malaga, Spain Peter Schmid-Grendelmeier, University Hospital Zurich, Switzerland Stephen A Tilles, Northwest Asthma and Allergy Center, USA Massimo Triggiani, University of Salerno, Italy Ronald van Ree, Academic Medical Center, Amsterdam, Netherlands Thomas Werfel, Hannover Medical School, Germany Founding Editor Jan Lötvall, Göteborg University, Sweden